Mr. James Durward reports

NDATALYZE ADVANCES YMI THROUGH A MARKETING CONTRACT

Ndatalyze Corp. has entered into a marketing contract with Venture Communications (VenComm) to introduce YMI to the consumer mobile health (mHealth) market beginning in the fall of 2022.

"This multifaceted contract involves a totally new user experience (UX), public relations, social media aspects including common platforms, influencers, brand ambassador(s)/spokesperson(s), print and electronic media, and overall marketing management. We have been working with VenComm for many months and are highly confident in the success of the plan they developed for YMI," said Ndatalyze's president, Jim Durward.

The corporation expects delivery of the new UX by the end of August, whereafter it will be integrated with the existing fully functional machine-learning platform in advance of public release by October, 2022. Initial revenues are expected to commence by calendar year-end, 2022. The VenComm marketing contract is fully financed by the corporation's cash position of approximately $1.2-million.

About Ndatalyze Corp.

Ndatalyze generates technology-based, health-related solutions. The YMI division is developing a machine-learning-based, on-line consumer mental health application, and the database sales division is focusing on providing a specialized health-related reference database to application developers and researchers. YMI is based on the corporation's proprietary reference database consisting of greater than 1,200 biometric records complete with electroencephalogram (EEG) same-time-of-day data. With installations worldwide, the Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI is in development, and, accordingly, the corporation cannot accurately predict if or when this application will become a cash flow generator.

We seek Safe Harbor.